Liberty Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-46
Closed -$12K 891
2021
Q3
$12K Buy
46
+21
+84% +$5.74K ﹤0.01% 792
2021
Q2
$6K Hold
25
﹤0.01% 766
2021
Q1
$5K Hold
25
﹤0.01% 704
2020
Q4
$5K Sell
25
-9
-26% -$1.79K ﹤0.01% 699
2020
Q3
$6K Sell
34
-13
-28% -$2.4K ﹤0.01% 604
2020
Q2
$9K Sell
47
-3
-6% -$491 0.01% 518
2020
Q1
$7K Sell
50
-3
-6% -$478 0.01% 522
2019
Q4
$8K Hold
53
0.01% 594
2019
Q3
$7K Sell
53
-7
-12% -$917 0.01% 594
2019
Q2
$7K Hold
60
0.01% 601
2019
Q1
$6K Buy
+60
New +$6.19K ﹤0.01% 521

Other funds holding RMD

Liberty Wealth Management's RMD Position: Q4 2021 in Review

Liberty Wealth Management sold out of ResMed (RMD) in Q4 2021, closing a stake of 46 shares — an estimated $12K sold.

Liberty Wealth Management first reported a position in RMD in Q1 2019 and held it in 11 quarters. The position peaked at $12K in Q3 2021. 723 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • Liberty Wealth Management reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 46 ResMed shares in Q4 2021, an estimated $12K.
  • Liberty Wealth Management first reported a position in ResMed in Q1 2019 and held it in 11 quarters.
  • Liberty Wealth Management's ResMed position peaked at $12K in Q3 2021.
  • 723 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.